In August 2013, the FDA issued a drug safety communication advising the public that it was requiring a label-change to Cipro and other fluoroquinolones antibiotics. The FDA’s newest alert requires that all drug labels and medication guides for fluoroquinolones be updated to better emphasize the risk for serious and potentially irreversible peripheral neuropathy, which can occur soon after treatment begins.
Fluoroquinolones are among the most commonly prescribed class of antibiotics in the United States. These medicines include Cipro (ciprofloxacin), Levaquin (levofloxacin), Avelox (moxifloxacin), Factive (gemifloxacin), Noroxin (norfloxacin), and Floxin (ofloxacin). These drugs are used to treat a wide variety of bacterial infections such as certain types of pneumonia, bronchitis, urinary tract infections and skin infections.
Peripheral neuropathy is damage to the nerves that send information to and from the brain and spinal cord and the rest of the body. Damage interrupts this connection, and the symptoms depend on which nerves are affected. Numbness, tingling, burning, and shooting pain in the arms and legs are some of the most common symptoms.
Dubendorf Law Firm is currently working with a group of legal and medical professionals on behalf of hundreds of individuals possibly harmed by fluoroquinolones.